Skip to main content

19 February 2024 - Pharmacy - Oral evidence

Committee Health and Social Care Committee
Inquiry Pharmacy

Monday 19 February 2024

Start times: 4:00pm (private) 4:30pm (public)

Add to calendar

MPs to examine impact of medicine shortages on patients

MPs will examine the impact of medicine shortages on pharmacists and patients, particularly people with type 2 diabetes, in the third session of the pharmacy inquiry. Funding of community pharmacy services and the rollout of Pharmacy First will also be covered.

Meeting details

At 4:00pm: Private discussion
Inquiry Pharmacy
At 4:30pm: Oral evidence
Inquiry Pharmacy
Director of Pharmacy Funding at Community Pharmacy England
Chief Executive at Community Pharmacy England
Head of Policy, Campaigns and Mobilisation at Diabetes UK
At 5:20pm: Oral evidence
Inquiry Pharmacy
Director, Distribution and Supply at The Association of the British Pharmaceutical Industry (ABPI)
CEO at British Generic Manufacturers Association (BGMA)

The profession has called for a review of the Community Pharmacy Contractual Framework, coupled with a long-term sustainable funding commitment. Research in 2022 found that community pharmacy funding levels had fallen by more than 30% in real terms.

Questions are expected on the ability of community pharmacies to deliver on Pharmacy First – pharmacists prescribing medication directly for seven common conditions – after some concern that the launch at the end of January had been ‘hurried’.

The inquiry is examining challenges facing the pharmacy sector in hospitals, the community and general practice.


Room 16, Palace of Westminster

How to attend